Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen for ocular pain and migraine headache induced by trochleitis
IRCT20180114038350N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ibuprofen in Trochleitis, sponsored by Kurdistan University of Medical Sciences. Primary endpoints: Headache, Tenderness and 2 more. Started Jan 2018; status: completed.
02
Drugs
ibuprofen
03
Conditions
Trochleitis
Beyond the preview
Go deeper on IRCT20180114038350N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180114038350N1.